It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mutations in mexZ, encoding a negative regulator of the expression of the mexXY efflux pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung infection. Although traditionally related to resistance to the first-line drug tobramycin, mexZ mutations are associated with low-level aminoglycoside resistance when determined in the laboratory, suggesting that their selection during infection may not be necessarily, or only, related to tobramycin therapy. Here, we show that mexZ-mutated bacteria tend to accumulate inside the epithelial barrier of a human airway infection model, thus colonising the epithelium while being protected against diverse antibiotics. This phenotype is mediated by overexpression of lecA, a quorum sensing-controlled gene, encoding a lectin involved in P. aeruginosa tissue invasiveness. We find that lecA overexpression is caused by a disrupted equilibrium between the overproduced MexXY and another efflux pump, MexAB, which extrudes quorum sensing signals. Our results indicate that mexZ mutations affect the expression of quorum sensing-regulated pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within patients, something unnoticeable using standard laboratory tests.
Mutations in mexZ, encoding a negative regulator of efflux pump genes, are frequently acquired by Pseudomonas aeruginosa during early lung infection, but do not confer high antibiotic resistance as measured in lab tests. Here, Laborda et al. show that mexZ mutations affect quorum sensing pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within tissues.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Rigshospitalet, Department of Clinical Microbiology 9301, Copenhagen, Denmark (GRID:grid.475435.4); Technical University of Denmark, The Novo Nordisk Foundation Center for Biosustainability, Kgs. Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870)
2 Rigshospitalet, Department of Clinical Microbiology 9301, Copenhagen, Denmark (GRID:grid.475435.4)
3 CSIC, Centro Nacional de Biotecnología, Madrid, Spain (GRID:grid.428469.5) (ISNI:0000 0004 1794 1018)
4 CSIC, Centro Nacional de Biotecnología, Madrid, Spain (GRID:grid.428469.5) (ISNI:0000 0004 1794 1018); Universidad de Sevilla, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen Macarena, CSIC, Sevilla, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229); Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
5 Rigshospitalet, Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Copenhagen, Denmark (GRID:grid.475435.4)
6 Technical University of Denmark, The Novo Nordisk Foundation Center for Biosustainability, Kgs. Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870)
7 Rigshospitalet, Department of Clinical Microbiology 9301, Copenhagen, Denmark (GRID:grid.475435.4); University of Copenhagen, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)